Akba stock news

Akba stock news DEFAULT

Akebia Therapeutics Inc AKBA:NASDAQ


  • Open2.94
  • Day High2.97
  • Day Low2.91
  • Prev Close2.93
  • 52 Week High5.14
  • 52 Week High Date02/08/21
  • 52 Week Low2.09
  • 52 Week Low Date10/30/20
  • Market Cap512.27M
  • Shares Out174.54M
  • 10 Day Average Volume1.66M
  • Dividend-
  • Dividend Yield-
  • Beta1.63
  • YTD % Change4.77


  • EPS (TTM)-1.98
  • P/E (TTM)-1.48
  • Fwd P/E (NTM)-2.44
  • EBITDA (MRQ)-254.397M
  • ROE (MRQ)-109.96%
  • Revenue (MRQ)221.90M
  • Gross Margin (MRQ)31.22%
  • Net Margin (MRQ)-135.00%
  • Debt To Equity (MRQ)55.50%


  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

There is no recent news for this security.

There is no recent news for this security.

Sours: https://www.cnbc.com/quotes/AKBA

Akebia Therapeutics Inc Stock , AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney disease. The firm also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P.


Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Ownerin %
The Baupost Group LLC10.62
State Street Corp.8.75
SSgA Funds Management, Inc.8.75
Vanguard Group, Inc. (Subfiler)7.38
SPDR S&P Biotech ETF6.79
Wellington Management Co. LLP6.71
Avidity Partners Management LP5.11
Consonance Capital Management LP4.98
Nantahala Capital Management LLC4.75
BlackRock Fund Advisors4.45
Abrams Capital Management LP3.95
Wellington Mgmt. Funds (IE) Plc - Global Health Care Eq.3.86
Nantahala Capital Management LLC3.23
Satter Management Co. LP2.91

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Sours: https://markets.businessinsider.com/stocks/akba-stock
  1. Elasticsearch low level rest client example
  2. Hulk images gallery
  3. Deutz fuel filter
  4. Beard cartoon character
  5. Unc msw admissions

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provided by FactSet. Copyright 2019© FactSet Research Systems Inc. All rights reserved. Source: FactSet

Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Source: FactSet

Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet, Dow Jones

Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones

ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Sources: FactSet, Dow Jones

Bonds: Bond quotes are updated in real-time. Sources: FactSet, Tullett Prebon

Currencies: Currency quotes are updated in real-time. Sources: FactSet, Tullett Prebon

Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Source: FactSet

Data are provided 'as is' for informational purposes only and are not intended for trading purposes. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. All rights reserved. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies)

Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: Kantar Media

Sours: https://www.wsj.com/market-data/quotes/AKBA
AKBA Stock 🔥 Akebia Therapeutics TOP STOCKS TO BUY NOW 🚀


News akba stock




Similar news:


164 165 166 167 168